Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators

Area of Science:

• Molecular Biology
• Genetics
• Drug Discovery

Background:

• MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression.
• miRNA deregulation is linked to various cancers, with oncogenic miRNAs overexpressed and tumor suppressors underexpressed.
• Targeting oncogenic miRNAs presents a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

• To outline three primary strategies for discovering small-molecule drugs that selectively interfere with oncogenic miRNAs.
• To provide a framework for developing novel anti-cancer therapeutics by modulating miRNA activity.

Main Methods:

• High-throughput screening of large compound libraries.
• Focused screening of small molecule libraries known to interact with RNA.
• Structure-based drug design targeting RNA secondary structures or miRNA pathway enzymes.

Main Results:

• Identification and development of three distinct approaches for oncogenic miRNA drug discovery.
• Demonstration of feasibility for selective interference with oncogenic miRNAs using small molecules.

Conclusions:

• The presented strategies offer a comprehensive approach to developing targeted therapies for cancers driven by miRNA dysregulation.
• Further research into these methods can lead to novel small-molecule drugs for effective cancer treatment.